# The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury

Study · id `cardio:ct-nct05095857` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05095857](<https://clinicaltrials.gov/study/NCT05095857>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05095857

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.

## Technical summary

Registry record NCT05095857. Randomized; quadruple masking; primary purpose treatment. Start 2023-09-15 (actual); primary completion 2028-09-15 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT05095857, source copy `cardio:ctgov-nct05095857-2024-06-26`, retrieved 2026-10-31)
- Started: 2023-09-15 (actual) (ClinicalTrials.gov record NCT05095857, source copy `cardio:ctgov-nct05095857-2024-06-26`, retrieved 2026-10-31)
- Primary completion: 2028-09-15 (anticipated) (ClinicalTrials.gov record NCT05095857, source copy `cardio:ctgov-nct05095857-2024-06-26`, retrieved 2026-10-31)
- Completion: 2028-09-15 (anticipated) (ClinicalTrials.gov record NCT05095857, source copy `cardio:ctgov-nct05095857-2024-06-26`, retrieved 2026-10-31)
- Countries: Denmark (ClinicalTrials.gov record NCT05095857, source copy `cardio:ctgov-nct05095857-2024-06-26`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05095857-2024-06-26`, retrieved 2026-10-31)

## The registry's words

- Brief title: The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury
- Acronym: KETA-BID
- Condition: Subarachnoid Hemorrhage, Aneurysmal
- Condition: Intracerebral Hemorrhage
- Condition: Traumatic Brain Injury
- Intervention (Drug): S-ketamine
- Intervention (Other): Isotonic saline (placebo)
- Lead sponsor: Copenhagen University Hospital, Rigshospitalet
- Lead sponsor class: OTHER
- Collaborator: Copenhagen Trial Unit, Center for Clinical Intervention Research
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry lists this organization as the lead sponsor: Copenhagen University Hospital, Rigshospitalet (`cardio:org-copenhagen-university-hospital-rigshospitalet`)

## Provenance

Content hash: b75c746b027ae42126f7a2d0ee15b396db2ab753871d74b7b2c6ae311ef3bb4c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
